|
|
|
|
|
|
|
|
|
|
Previous: CALYPTE BIOMEDICAL CORP, 10-Q, EX-10.78, 2000-11-07 |
Next: HUMAN GENOME SCIENCES INC, 424B3, 2000-11-07 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 3,273
<SECURITIES> 0
<RECEIVABLES> 775
<ALLOWANCES> (35)
<INVENTORY> 1,019
<CURRENT-ASSETS> 6,074
<PP&E> 5,850
<DEPRECIATION> (4,296)
<TOTAL-ASSETS> 7,836
<CURRENT-LIABILITIES> 3,352
<BONDS> 104
2,306
0
<COMMON> 25
<OTHER-SE> 2,016
<TOTAL-LIABILITY-AND-EQUITY> 7,836
<SALES> 2,962
<TOTAL-REVENUES> 2,962
<CGS> 4,495
<TOTAL-COSTS> 4,495
<OTHER-EXPENSES> 7,034
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (93)
<INCOME-PRETAX> (8,409)
<INCOME-TAX> (2)
<INCOME-CONTINUING> (8,501)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (8,501)
<EPS-BASIC> (0.36)
<EPS-DILUTED> (0.36)
</TABLE>
|
|